The
iShares Nasdaq Biotechnology ETF (IBB)
held about 3.5 percent lower after earlier falling more than 5 percent
and briefly dragging the Nasdaq composite into negative territory.
Paul Yook, portfolio manager at BioShares Funds, attributed the
declines in IBB to disappointment on earnings. "Generally, companies
were pretty conservative with their guidance," he said.
"It's just been obviously the worst beginning to the year for biotech
and investors are really fleeing and staying on the sidelines until they
see some stabilization (in stock prices)," he said.
As of intraday trade Thursday, the iShares Nasdaq Biotechnology ETF (IBB) was down more than 20 percent for the year so far.
"My sense is it's going to take some more catalysts to turn things
around," said Mike Bailey, director of research and chair at FBB Capital
Partners. "Unfortunately, fourth-quarter earnings season is not doing
it."
Celgene
fell more than 5.5 percent in afternoon trade. The firm posted
fourth-quarter earnings that fell short of analysts' estimates, hurt by
higher costs. The company's net profit fell to $561 million, or 69 cents
per share, in the fourth quarter, from $613.9 million, or 74 cents per
share, a year earlier, Reuters reported. The firm's current quarter
earnings guidance was slightly below FactSet expectations.
Eli Lilly
also declined more than 5.5 percent in afternoon trade. The drug maker
posted earnings in-line with estimates on revenue that beat. Lilly said
it is upbeat about this year's prospects based on a half dozen Food and
Drug Administration approvals in 2015 and a number of successful
late-stage trials.
Amazon.com,
Microsoft,
Visa and
Electronic Arts are among companies due to report after the bell.
Read MoreDon't be fooled by the flimsy rebound in stocks
The
S&P 500 also tried for gains as energy held more than 2.5 percent
higher, while health care declined more than 2 percent as the only
decliner in afternoon trade. Earlier, energy gained more than 3.5
percent to lead S&P 500 advancers, with the index spiking 1 percent
in opening trade.
"The huge higher open was clearly around oil prices higher and the talk about OPEC cutting production," Bredemus said.
"I think the reality is setting in. I think reality is, after the Fed,
is the Fed isn't seeing anything better than we are," he said. "It's
earnings season. Things are slow, things aren't going as well as we
hoped and oil is uncertain."
Earlier, Dow futures jumped more
than 150 points in pre-market trade, shaking off pressure from a sharp
miss on durable goods, as oil gained.
"Obviously,
certainly crude is driving the bus," said Jeremy Klein, chief market
strategist at FBN Securities. He also noted support for stocks from some
encouraging earnings reports and expectations the Federal Reserve will
hold off on raising rates in the near-term.
U.S. crude
settled up 92 cents, or 2.85 percent, at $33.22 a barrel, well off
session highs. Earlier, WTI surged above $34.50 to its highest since
Jan. 6.
Brent traded just above $34 a barrel in afternoon
trade after earlier topping $35.50 a barrel on speculation that major
producers may cooperate to cut production.
Russian Energy
Minister Alexander Novak said Thursday that Saudi Arabia had proposed to
cut oil production by up to 5 percent by each country in order to
support weak oil prices, Reuters reported.
But Saudi Arabia has not proposed cutting back production or asked Russia to do the same, Dow Jones reported, citing a senior Gulf OPEC delegate.
Read MoreChances of OPEC, Russia oil deal slim to none
U.S. stocks fell more than 1 percent Wednesday after the Federal
Reserve meeting statement renewed concerns about global growth.
Disappointing earnings reports from Apple and Boeing also weighed
heavily on stocks, despite gains in oil prices.
"I think
they're trying to convey a very nuanced message and investors were
looking for something that would say they wouldn't raise rates at the
March meeting," said Kate Warne, investment strategist at Edward Jones.
Pending home sales rose just 0.1 percent in December from a downwardly revised November print.
Treasury yields briefly turned higher as oil surged before holding lower in afternoon trade, with the
10-year yield at 1.98 percent and the
2-year yield at 0.81 percent.
The Treasury auctioned $29 billion in 7-year notes at a high yield of 1.759 percent.
The U.S. dollar traded nearly half a percent lower against major world
currencies, with the euro around $1.096 and the yen at 118.70 yen
against the greenback.
In corporate news,
Facebook
reported earnings after the close Wednesday that blew past estimates,
with the firm beating the $1 billion mark in quarterly net income for
the first time ever.
Caterpillar
reported adjusted fourth quarter profit of 74 cents per share, five
cents above estimates, though revenue was light. Caterpillar does see
full-year 2016 profit above current Street estimates, as it benefits
from cost controls and restructuring. Shares rose more than 4 percent in
afternoon trade.
Dow futures briefly turned negative in pre-market trade after December durable goods orders declined far more than expected.
"While it wasn't good news, it was also not new news. I don't think that set the tone for today," Warne said.
Durable goods fell 5.1 percent in December, far more than expectations for a less-than 1 percent decline. Ex-transportation, the figure declined 1.2 percent.
"That's another indication the economy is continuing to slow and an
indication the Fed is going to hold off in the first half of this year,"
said Peter Cardillo, chief market economist at First Standard
Financial.
Read More Factory slowdown hits these states hardest
Weekly jobless claims came in at 278,000.
Treasury yields edged lower after the durable goods report, with the
10-year dipping below 2 percent, before mostly turning higher as oil
climbed.